Experience in the use of tocilizumab in patient with systemic juvenile idiopathic arthritis and type 1 diabetes
The article describes the experience of using tocilizumab in a patient with systemic juvenile idiopathic arthritis (JIA) refractory to therapy with classical immunosuppressants, coupled with type 1 diabetes. Already after the first injection of tocilizumab there was a decrease in the severity of the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2016-06-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1401 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|